人乳头瘤病毒疫苗作用聚焦
本文综述人乳头瘤病毒(HPV)疫苗在特定人群中的作用,包括治疗后人群、老年人、HIV阳性者及实体器官移植受者。作者观察到疫苗在这些人群可能有效,但需进一步证据评估成本效益。
要点
- 在特定人群(如治疗后、老年人、HIV阳性者、实体器官移植受者)中,疫苗可能有效。
- 需进一步证据评估这些人群接种疫苗的成本效益。
- adolescent和年轻成人接种HPV疫苗具有成本效益。
核心结论
- 疫苗在特定人群(如治疗后、老年人、HIV阳性者、实体器官移植受者)中可能有效,但需进一步证据评估成本效益。
研究设计与样本
- 本文为综述,评估HPV疫苗在特定人群中的作用。
主要发现
- 在特定人群(如治疗后、老年人、HIV阳性者、实体器官移植受者)中,疫苗可能有效。
- 需进一步证据评估这些人群接种疫苗的成本效益。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需进一步证据评估特定人群接种疫苗的成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In high income setting, the massive implementation of screening programs has reduced the incidence of cervical cancer, dramatically. However, cervical cancer still remains a major health concern, being one of the most common cause of death for cancer among women. The adoption of primary prevention through vaccination against HPV aims to reduce the prevalence of HPV-related lesions and cervical cancer. Accumulating data highlighted the cost-effectiveness of introducing HPV vaccination for adolescent and young adults. In the present review, we critically evaluated the role of vaccination against HPV, focusing much more on the role of vaccination in specific cluster of subjects (eg, post-treatment and older adults). Additionally, we evaluated the available evidence on the role of vaccination in HIV-positive subjects and in women receiving solid organs transplantation. We observed that although vaccination might be considered effective in those cluster of subjects; further evidence is needed to assess the cost-effectiveness of vaccination in these settings.
引用
- Bogani G, Raspagliesi F, di Donato V, et al. Spotlight on the role of human papillomavirus vaccines. Gynecol Oncol. 2020. PMID: 32943207. doi:10.1016/j.ygyno.2020.08.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。